cell immunoregulatory cytokine patterns in chronic hepatitis B patients & correlate them in response to interferon therapy. Study comprised of two groups. Group A included 25 treatment naïve chronic hepatitis…
both groups. Results: The pretreatment parameters significantly associated with sustained virological response to interferon therapy were low levels of serum ... infected patients. Conclusion: Pretreatment parameters…
Changes in body weight in HCV patients on interferon therapy are well established. However, these are not reported extensively in patients from developing societies, where the infection may have different ... effects of…
analytical study followed 30 patients with chronic hepatitis C (CHC) treated with combination therapy with pegylated interferon alpha with Ribavirin (PEG-IFNα + RBV) for one year ... patients. Major depressive disorder…
Pakhtunkhwa (KPK) is one of the main affected provinces of the country. Since Interferon (IFN) based therapy is used to eradicate the infection from the bodies of infected individuals. However
chronic hepatitis B (CHB) patients and predicted its efficacy after pegylated interferon a-2a (Peg-INFa-2a) therapy. Sixty-three cases of HbeAgpositive CHB inpatients and outpatients, treated
Interferon α (IFNα) has been reported to induce several autoimmune diseases, including autoimmune thyroiditis (AITD) and type 1 diabetes (T1D). In addition, co-occurrence of T1D and AITD is well ... Japanese woman with…
different stages and examined the changes in its content before and after interferon α (IFN-α) therapy with related to healthy subjects. The 199 HCV patients of both genders
investigated that the Interferon-α (IFN-α) therapy to patients with hepatitis C are correlated with iron levels in serum. The aim and objective of this study was to test
minimal change disease. The clinical condition started to improve gradually upon cessation of the Interferon therapy and concomitant treatment with prednisolone. The patient attained full and sustained remission after…
clinical case is to attract attention of the dangerous possible risks of the therapy with Interferon at the patients with chronic hepatitis virus B or virus C positive who follow ... creatinine=0.9mg/dl. After the…
This study aimed to evaluate the effect of hepatic therapy combination (interferon, sovaldi & ribavirin) on type 4 hepatitis C viral strain by comparing the results of liver function tests before ... results and Group…
versus clinical management of 42 patients who were treated with telaprevir/ peg interferon/ribavirin based therapy for a reporting period 2011-2013. All 40 patients completed therapy with 37 attaining ... patient with…
this clinical case presentation is to attract attention to the risk of therapy with interferon and ribavarin. Materials & Method: I present the clinical case of a woman patient 44 years ... histopathological diagnosis…
virus. The development of Type 1 diabetes mellitus, however, is usually associated with therapy with interferon α for hepatitis C virus infection with development of anti islet cell antibodies ... discuss hepatitis C…
Background: Recombinant interferon β is now the mainstay of maintenance therapy for multiple sclerosis in many countries. Retinal lesions are rarely related with subcutaneous interferon β1α in multiple sclerosis…
long-term efficacy of Telbivudine (LdT) between patients with poor response to interferon-alpha (IFN-α) therapy and those without antiviral history is unknown. Herein, we investigated and compared
related chronic liver disease compared to HCV monoinfected individuals. For many years PEGylated interferon -2a/2b (PEG-IFN-2a/2b) and an antiviral drug ribavirin (RBV) have been ... response in a cohort of HIV-1/HCV…